31 October 2024
31 October 2024
Pharmaceutical management expert Kenneth Getz shares insights on broader trends in the pharma sector influencing the recent wave of layoffs.
Amid a share value slump and executive turmoil, Pfizer reported a robust quarter, thanks in part to Covid-19 drug sales.
Barman-Aksӧzen shared her experience of guiding treatment research for her own ultra rare disorder, erythropoietic protoporphyria (EPP).
Neomorph will receive an upfront payment and may earn contingent milestone payments as the collaboration advances.
Green chemistry has the potential to revolutionise the pharmaceutical industry.
Bladder cancer is the ninth most common cancer worldwide, and the number of diagnosed incident cases is set to increase.
Lilly’s Alzheimer’s drug Kisunla was approved in the US, Japan, and the UK, among other countries.
Beyond the potential for improved patient outcomes, the treatment could ease the healthcare burden in malaria-endemic regions.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
